Eskopolamina

Aldatu loturak

Eskopolamina

Formula kimikoa	C₁₇H₂₁NO₄
SMILES kanonikoa	2D eredua
SMILES isomerikoa	CN1[C@@H]2C[C@H](C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4
MolView	3D eredua
Konposizioa	Nitrogeno,oxigeno,karbono etahidrogeno
Mota	LSM-4015^(en)
Estereoisomeroa	[[(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate\|(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate]]^(en),(+)-Scopolamine^(en) eta [[(1R,2S,4R,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate\|(1R,2S,4R,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate]]^(en)
Masa molekularra	303,1471 Da
Erabilera
Konposatu aktiboa	Transderm Scop^(en)
Tratatzen du	disenteria,postencephalitic Parkinson disease^(en),errinitis basomotor,kolonaren gaixotasun,dibertikulitis,aurpegiko paralisi,iridocyclitis^(en) etazinetosi
Haurdunaldia	Australian pregnancy category B2^(en) etaUS pregnancy category C^(en)
Rola	muscarinic antagonist^(en),serotonin antagonist^(en),H1 antagonist^(en) etafarmako esentzial
Identifikatzaileak
InChlKey	STECJAGHUSJQJN-FWXGHANASA-N
CAS zenbakia	51-34-3
ChemSpider	10194106
PubChem	153311
Reaxys	91904
Gmelin	16794
ChEMBL	CHEMBL569713
ZVG	510356
EC zenbakia	200-090-3
ECHA	100.000.083
MeSH	D012601
RxNorm	9601
Human Metabolome Database	HMDB0003573
KNApSAcK	C00002292
UNII	DL48G20X8X
NDF-RT	N0000146728
KEGG	D00138

Eskopolamina

Formula kimikoa

C₁₇H₂₁NO₄

SMILES kanonikoa

2D eredua

SMILES isomerikoa

CN1[C@@H]2C[C@H](C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4

MolView

3D eredua

Konposizioa

Nitrogeno,oxigeno,karbono etahidrogeno

Mota

LSM-4015^(en)

Estereoisomeroa

[[(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate|(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate]]^(en)

,(+)-Scopolamine^(en)

eta [[(1R,2S,4R,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate|(1R,2S,4R,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate]]^(en)

Masa molekularra

303,1471 Da

Erabilera

Konposatu aktiboa

Transderm Scop^(en)

Tratatzen du

disenteria,postencephalitic Parkinson disease^(en)

,errinitis basomotor,kolonaren gaixotasun,dibertikulitis,aurpegiko paralisi,iridocyclitis^(en)

etazinetosi

Haurdunaldia

Australian pregnancy category B2^(en)

etaUS pregnancy category C^(en)

Rola

muscarinic antagonist^(en)

,serotonin antagonist^(en)

,H1 antagonist^(en)

etafarmako esentzial

Identifikatzaileak

InChlKey

STECJAGHUSJQJN-FWXGHANASA-N

CAS zenbakia

51-34-3

ChemSpider

10194106

PubChem

153311

Reaxys

91904

Gmelin

16794

ChEMBL

CHEMBL569713

ZVG

510356

EC zenbakia

200-090-3

ECHA

100.000.083

MeSH

D012601

RxNorm

9601

Human Metabolome Database

KNApSAcK

UNII

NDF-RT

KEGG

i e a Antzinakoanestesia
Landare / animalia	Astaperrexil handi Belaiki Cannabis Castoreum Datura inoxia Datura metel Erabelar Irabelar Koka Lactuca virosa Lo-belar Mandragora Sahats Saussurea
Biografiak	Abulkasis Al-Razi Avenzoar Avizena Dioskorides Galeno Hipokrates Sabuncuoğlu Sushrutha Teofrasto Zeltso Zhang
Konposatuak	Akonitina Atropina Eskopolamina Kokaina Hiosziamina Morfina Salizilato Δ9-THC Zikutina

Movatterモバイル変換

Eskopolamina

Erreferentziak

Kanpo estekak